Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)
Clinical trial NCT05495269 · COMPLETED
Trial details
- NCT number
- NCT05495269
- Sponsor
- Qlaris Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-23
- Primary completion
- 2023-01-25
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.